Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Spanish Lung Cancer Group

Bookmark and Share

ESMO 33

12 - 16 Sep 2008
Published: 3 Dec 2008
Views: 16559
Rating:
Save
Prof. Rafael Rosel
Benefits of customising erlotinib therapy for NSCLC.

Related Videos

The role of lymph nodes in stage 3 lung cancer
Prof Walter Weder - Privatklinik Bethanien,Zürich, Switzerland
The role of lymph nodes in stage 3 lung cancer ( Prof Walter Weder - Privatklinik Bethanien,Zürich, Switzerland )
1 Feb 2023
Developments in surgery for early stage lung cancer
Prof Walter Weder - Privatklinik Bethanien, Zürich, Switzerland
Developments in surgery for early stage lung cancer ( Prof Walter Weder - Privatklinik Bethanien, Zürich, Switzerland )
1 Feb 2023
The role of multidisciplinary tumour board in managing stage 3 lung cancer
Prof Walter Weder - Privatklinik Bethanien, Zürich, Switzerland
The role of multidisciplinary tumour board in managing stage 3 lung cancer ( Prof Walter Weder - Privatklinik Bethanien, Zürich, Switzerland )
1 Feb 2023
Latest in lung cancer genomic testing
Prof Sanjay Popat - The Royal Marsden, London, UK
Latest in lung cancer genomic testing ( Prof Sanjay Popat - The Royal Marsden, London, UK )
26 Jan 2023
Complex technologies for advanced diagnosis and precision medicine in oncology
Dr Joaquin Mateo - Vall d’Hebron Institute of Oncology, Barcelona, Spain
Complex technologies for advanced diagnosis and precision medicine in oncology ( Dr Joaquin Mateo - Vall d’Hebron Institute of Oncology, Barcelona, Spain )
24 Oct 2022
Choosing wisely: Lung cancer
Prof Sabita Jiwnani - Tata memoriał hospital, Mumbai, India
Choosing wisely: Lung cancer ( Prof Sabita Jiwnani - Tata memoriał hospital, Mumbai, India )
24 Oct 2022
ESMO 2022: Lung roundup
Dr Luis Raez - Memorial Cancer Institute, Miami, USA
ESMO 2022: Lung roundup ( Dr Luis Raez - Memorial Cancer Institute, Miami, USA )
4 Oct 2022
Intraoperative Radiotherapy
Dr Mahima Pant - National Academy for Medical Sciences (NAMS), Kathmandu, Nepal
Intraoperative Radiotherapy ( Dr Mahima Pant - National Academy for Medical Sciences (NAMS), Kathmandu, Nepal )
25 Sep 2022
From clinic to practice in NSCLC patients with exon 20 mutations
Prof Nicolas Girard - Institut Curie, Paris, France
From clinic to practice in NSCLC patients with exon 20 mutations ( Prof Nicolas Girard - Institut Curie, Paris, France )
13 Sep 2022

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation